
EyeGate Pharmaceuticals, Inc. EYEG
EyeGate Pharmaceuticals, Inc. Operating Cycle 2011-2026 | EYEG
Annual Operating Cycle EyeGate Pharmaceuticals, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 32 | - | 67.1 | 71.4 | 63.7 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.4 | 32 | 58.6 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amgen
AMGN
|
282 | $ 350.62 | 0.81 % | $ 189 B | ||
|
Heron Therapeutics
HRTX
|
842 | $ 0.8 | 2.35 % | $ 133 M | ||
|
Altimmune
ALT
|
7.85 K | $ 3.46 | 3.44 % | $ 305 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
145 | $ 90.74 | -0.04 % | $ 17.7 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Inovio Pharmaceuticals
INO
|
1.91 K | $ 1.62 | 2.22 % | $ 35.9 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Kamada Ltd.
KMDA
|
269 | $ 8.23 | -0.24 % | $ 260 M | ||
|
Karyopharm Therapeutics
KPTI
|
72.5 | $ 7.06 | -7.47 % | $ 860 K | ||
|
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M | ||
|
Keros Therapeutics
KROS
|
4.72 | $ 11.27 | 2.83 % | $ 419 M | ||
|
Denali Therapeutics
DNLI
|
1.89 | $ 21.23 | 5.26 % | $ 3.49 B | ||
|
Longeveron
LGVN
|
28.6 | $ 0.95 | -3.52 % | $ 16.7 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.3 | 1.3 % | $ 714 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M |